top regimens by diagnostic group - ncin
TRANSCRIPT
Top Regimens by Diagnostic Group
April – July 2012
Introduction
The Top Regimens by Diagnostic Group report provides an overview of the most frequently administered regimens for major tumour sites.
Within the report, there may be some records present where the diagnosis does not match the treatment recorded. This report reflects how data has been submitted to CIU.
Oral chemotherapy may be under-represented, particularly for haematological groups such as myeloma.
Report Timeframe
This report excludes activity for patients under the age of 16 at the time of starting a regimen.
Only activity considered to be ‘In Year’ is included. The recency of activity is derived from all populated date fields.
Activity is considered to be ‘In Year’ if it occurs on or after 1st April 2012.
Definition of Terms The following terms are used in this report:
Number of Patients The number of unique patients with a primary diagnosis recorded that
matches the relevant diagnostic group.
Unique patients are identified by NHS number and postcode.
A patient that receives chemotherapy treatment for multiple diagnoses in different diagnostic groupings and within the reporting period specified will be counted more than once.
Number of First Cycles The number of patients with a primary diagnosis matching the relevant diagnostic group that have started a cycle of chemotherapy with a recognised regimen grouping.
Patients starting multiple different regimens will be counted once in each regimen group.
Total Cycles The aggregate total number of cycles delivered of the specified regimen to all patients with a primary diagnosis matching the relevant diagnostic group.
This will include first cycles.
Definition of Terms The following terms are used in this report:
All submitting trusts aggregated The total aggregated activity for all NHS hospital trusts that have
submitted data at the time the report was produced.
Coverage across diagnostic groups will vary as not all of the trusts are submitting data for all diagnostic groups at the time the report was produced.
Definition of Terms The following terms are used in this report:
Breast 6062(24%)
Lower GI3734(15%)
Lung2845(11%)
Lymphoma2172(9%)
Urology2139(9%)
Upper GI2071(8%)
Gynae1881(7%)
Myeloma890(4%)
Leukaemia772(3%)
Brain/CNS414(2%)
Head and Neck405(2%)
Other haematology
284(1%)
Other1376(5%)
Number of Patients by Diagnostic Group All submitting trusts aggregated. Patients aged 16 and over.
Data received for April - July 2012
Number of Patients by Diagnostic Group All submitting trusts aggregated. Patients aged 16 and over.
Data received for April - July 2012
Number of Patients by Diagnostic Group All submitting trusts aggregated. Patients aged 16 and over.
Data received for April - July 2012
Primary Diagnosis Sub Group
ALL
AML
CLL
CML
Hodgkin lymphoma
NHL aggressive
NHL indolent
NHL NOS
T/NK cell NHL
Myeloma plasma cell dyscrasias
MDS
MPD
890
Other haematology 63
192
Lymphoma 281
619
692
507
73
Number of Patients
(All submitting trusts aggregated)
Leukaemia 69
221
274
181
Top Regimens by Diagnostic Group Leukaemia (ALL) ICD10: C91.0, C91.5, C91.8
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Leukaemia (AML) ICD10: C92.0, C92.3-C92.6, C92.8, C93, C93.0, C93.7, C93.9, C94.0, C94.2-C94.4, C96.2, C96.4, C96.8
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Leukaemia (CLL) ICD10: C91.1
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Leukaemia (CML) ICD10: C92.1
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Lymphoma (Hodgkin lymphoma) ICD10: C81, C81.0-C81.4, C81.7, C81.9
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Lymphoma (NHL aggressive) ICD10: C82.4, C83.1, C83.3, C83.5, C83.7, C84.6, C84.7, C85.2
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Lymphoma (NHL indolent) ICD10: C82, C82.0-C82.3, C82.6, C82.7, C82.9, C83.0, C88.0, C88.4, C91.3, C91.4, C91.6, C91.7, C91.9
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Lymphoma (NHL NOS) ICD10: C82.5, C83, C83.8, C83.9, C85, C85.1, C85.7, C85.9, C88, C88.2, C88.3, C88.7, C88.9
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Lymphoma (T/NK cell NHL) ICD10: C84, C84.0, C84.1, C84.4, C84.5, C84.8, C84.9, C86, C86.0-C86.6
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Myeloma (plasma cell dyscrasias) ICD10: C90, C90.0-C90.3, D47.2, E85
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Other haematology (MDS) ICD10: C92.2, C93.1, C93.3, C94.6, D46, D46.0-D46.2, D46.4-D46.7, D46.9
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
Top Regimens by Diagnostic Group Other haematology (MPD) ICD10: D45, D47.1, D47.3-D47.5
All submitting trusts aggregated. Patients aged 16 and over
Data received for April - July 2012
www.chemodataset.nhs.uk
helpdesk 01865 334 783